{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:58:17Z","timestamp":1783504697789,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["17ck0106151h0003"],"award-info":[{"award-number":["17ck0106151h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","doi-asserted-by":"crossref","award":["24591838"],"award-info":[{"award-number":["24591838"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","doi-asserted-by":"crossref","award":["16K10390"],"award-info":[{"award-number":["16K10390"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ctro.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T02:30:55Z","timestamp":1507861855000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice"],"prefix":"10.1016","volume":"6","author":[{"given":"Haruo","family":"Inokuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Norihisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2017.09.005_b0005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(05)65855-7","article-title":"High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer","volume":"166","author":"Zelefsky","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ctro.2017.09.005_b0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2007.01.043","article-title":"Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer","volume":"68","author":"Vora","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijrobp.2012.05.023","article-title":"Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"85","author":"Spratt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0025","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2010.02.040","article-title":"Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer","volume":"80","author":"Sharma","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2013.07.041","article-title":"Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial","volume":"87","author":"Michalski","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10147-015-0867-7","article-title":"Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer","volume":"21","author":"Mizowaki","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ctro.2017.09.005_b0050","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ctro.2017.09.005_b0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10147-011-0324-1","article-title":"Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol","volume":"17","author":"Norihisa","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ctro.2017.09.005_b0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2009.03.013","article-title":"Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer","volume":"92","author":"Fonteyne","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2017.09.005_b0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.25467","article-title":"Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer","volume":"117","author":"Alicikus","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2017.09.005_b0070","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0075","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2007.04.076","article-title":"Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose\u2013volume analysis of a phase II dose-escalation study","volume":"69","author":"Harsolia","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1088\/0031-9155\/45\/2\/312","article-title":"Hardware-sensitive optimization for intensity modulated radiotherapy","volume":"45","author":"Cho","year":"2000","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2017.09.005_b0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1118\/1.1688214","article-title":"Speed and convergence properties of gradient algorithms for optimization of IMRT","volume":"31","author":"Zhang","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2017.09.005_b0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejmp.2012.10.002","article-title":"Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): sensitivity to TCP parameters","volume":"29","author":"Azzeroni","year":"2013","journal-title":"Phys Med"},{"key":"10.1016\/j.ctro.2017.09.005_b0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fonc.2014.00319","article-title":"Stereotactic body radiation therapy for prostate cancer: review of experience of a multicenter phase I\/II dose-escalation study","volume":"4","author":"Kim","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2017.09.005_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","article-title":"Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer","volume":"84","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563081730040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563081730040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:24:25Z","timestamp":1535329465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563081730040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":21,"alternative-id":["S240563081730040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2017.09.005","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between urinary dose and delayed radiation cystitis after 78Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}